Samuel Copt

Samuel Copt is a seasoned biostatistician with extensive experience in statistical evaluations across various domains, including biology, medicine, and toxicology. Currently serving as a Senior Biostatistician at Biosensors International since August 2013, Samuel has previously held prominent roles, including Senior Scientist in Statistics at Philip Morris International and Principal Biostatistician at Merck Serono, where expertise was provided for autoimmune diseases and fertility. Early career contributions include significant statistical support for the FIELD Study at the NHMRC Clinical Trial Centre, focusing on type 2 diabetes mellitus and cardiovascular events. Samuel holds a PhD in Statistics and a Master's in Econometry from the University of Geneva.